Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2053)
All Articles published online
|
Sep 7, 2007 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun L, Wu H, Pan WM, Guan YS. Positron emission tomography/computed tomography with 18F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma. World J Gastroenterol 2007; 13(33): 4529-4532 [PMID: 17724816 DOI: 10.3748/wjg.v13.i33.4529] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i33/4529.htm |
| Number | Citing Articles |
| 1 |
Long Sun, Yong-Song Guan, Wei-Min Pan, Zuo-Ming Luo, Ji-Hong Wei, Long Zhao, Hua Wu. Metabolic restaging of hepatocellular carcinoma using whole-body <sup>18</sup>F-FDG PET/CT. World Journal of Hepatology 2009; 1(1): 90-97 doi: 10.4254/wjh.v1.i1.90
|
| 2 |
Bing Wu, Yiqiu Zhang, Hui Tan, Hongcheng Shi. Value of 18F-FDG PET/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma. Abdominal Radiology 2019; 44(7): 2430 doi: 10.1007/s00261-019-01997-2
|
| 3 |
Mustafa Aras, Fuat Dede, Faysal Dane, Bilge Aktas, Halil Turgut Turoglu. FDG PET/CT Appearance of Portal Vein Tumor Thrombus in the Gastric Primitive Neuroectodermal Tumor. Clinical Nuclear Medicine 2013; 38(1): 47 doi: 10.1097/RLU.0b013e3182708530
|
| 4 |
Elaine Yuen Phin Lee, Pek-Lan Khong. The Value of 18F-FDG PET/Contrast-Enhanced CT in Detection of Tumor Thrombus. Clinical Nuclear Medicine 2013; 38(2): e60 doi: 10.1097/RLU.0b013e318266d53e
|
| 5 |
Long Sun, Yong-Song Guan, Wei-Ming Pan, Gui-Bing Chen, Zuo-Ming Luo, Ji-Hong Wei, Hua Wu. Highly metabolic thrombus of the portal vein: <sup>18</sup>F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(8): 1212-1217 doi: 10.3748/wjg.14.1212
|
| 6 |
Ginseppe Garcea, Seok Ling Ong, Guy J. Maddern. The current role of PET-CT in the characterization of hepatobiliary malignancies. HPB 2009; 11(1): 4 doi: 10.1111/j.1477-2574.2008.00009.x
|
| 7 |
Lai-Chun Ong, In-Chin Song, Yi Jin, Irene H. C. Kee, Eeyan Siew, Sidney Yu, Choon-Hua Thng, Hung Huynh, Pierce K. H. Chow. Effective Inhibition of Xenografts of Hepatocellular Carcinoma (HepG2) by Rapamycin and Bevacizumab in an Intrahepatic Model. Molecular Imaging and Biology 2009; 11(5): 334 doi: 10.1007/s11307-009-0213-4
|
| 8 |
Qing-Feng Xiong, Yue Chen. Review: Deoxyglucose Compounds Labeled with Isotopes Different from 18-Fuoride: Is There a Future in Clinical Practice?. Cancer Biotherapy and Radiopharmaceuticals 2008; 23(3): 376 doi: 10.1089/cbr.2007.0443
|
| 9 |
Shengping Hu, Jian Zhang, Chao Cheng, Qinghua Liu, Gaofeng Sun, Changjing Zuo. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdominal Imaging 2014; 39(6): 1221 doi: 10.1007/s00261-014-0170-5
|